M.D.C. Holdings, Inc. MDC
62.98 0.00 (+0.00%)
At closeApr 18, 2024, 4:00 PM EDT
62.97 Day range 62.99
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 51.00
Ratings (0m) 12 0 buy · 8 hold · 4 sell
- Strong buy0
- Buy0
- Hold8
- Sell4
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 5
- 2 months ago 7
- 3 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.34 | 1.34 – 1.34 | 1.08 | +24.1% | 1.23B | +39.5% | 1 |
| Next quarter | 1.57 | 1.57 – 1.57 | 1.24 | +26.6% | 1.36B | +45.5% | 1 |
| Current year | 5.70 | 5.70 – 5.70 | 5.29 | +7.8% | 5.04B | +8.6% | 1 |
| Next year | 5.61 | 5.61 – 5.61 | 5.70 | -1.6% | 5.30B | +5.1% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 2, 2023 | Raymond James | Maintained | Outperform | Outperform |
| Jul 30, 2023 | Wedbush | Maintained | Neutral | Neutral |
| Jul 13, 2023 | Raymond James | Upgrade | Market Perform | Outperform |
| Jun 13, 2023 | Seaport Global | Initiated | — | Neutral |
| May 2, 2023 | Wedbush | Reiterated | — | Neutral |
| Mar 5, 2023 | JP Morgan | Maintained | — | Underweight |
| Nov 21, 2022 | JP Morgan | Downgrade | Neutral | Underweight |
| Nov 2, 2022 | JP Morgan | Maintained | — | Neutral |
| Oct 30, 2022 | Wedbush | Maintained | Neutral | Neutral |
| Oct 20, 2022 | Raymond James | Downgrade | Strong Buy | Market Perform |
| Jul 31, 2022 | Raymond James | Maintained | — | Strong Buy |
| Jul 11, 2022 | JP Morgan | Maintained | — | Neutral |
| Jun 16, 2022 | Wells Fargo | Downgrade | Equal-Weight | Underweight |
| Apr 12, 2022 | JP Morgan | Maintained | — | Neutral |
| Mar 9, 2022 | JP Morgan | Maintained | — | Neutral |
| Nov 7, 2021 | Raymond James | Maintained | — | Strong Buy |
| Oct 13, 2021 | JP Morgan | Downgrade | Overweight | Neutral |
| Aug 18, 2021 | Raymond James | Maintained | — | Strong Buy |
| Apr 15, 2021 | Wells Fargo | Initiated | — | Equal-Weight |
| Mar 15, 2021 | Wolfe Research | Initiated | — | Peer Perform |
| Mar 11, 2021 | B of A Securities | Downgrade | Neutral | Underperform |
| Feb 1, 2021 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Jan 24, 2021 | Raymond James | Maintained | — | Strong Buy |
| Jan 4, 2021 | B of A Securities | Downgrade | Buy | Neutral |
| Oct 29, 2020 | Wells Fargo | Upgrade | Underweight | Equal-Weight |
| Oct 7, 2020 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 14, 2020 | B of A Securities | Upgrade | Neutral | Buy |
| Jul 28, 2020 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Jul 28, 2020 | JP Morgan | Maintained | — | Neutral |
| Jun 4, 2020 | Evercore ISI Group | Downgrade | Outperform | In-Line |